SharePost Content Read More Yahoo Finance #finance Post navigation Goldman Sachs Reiterates a Hold Rating on Viatris (VTRS) With a $10 PT RBC Capital Maintains a Buy Rating on Dyne Therapeutics (DYN) With a $25 PT